Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2023

SELL
$241.42 - $282.29 $8,449 - $9,880
-35 Reduced 3.52%
960 $254,000
Q3 2022

Oct 14, 2022

SELL
$247.06 - $1507.4 $47,188 - $287,913
-191 Reduced 16.1%
995 $257,000
Q2 2022

Jul 15, 2022

SELL
$237.11 - $299.66 $19,443 - $24,572
-82 Reduced 6.47%
1,186 $301,000
Q1 2022

Apr 29, 2022

SELL
$257.27 - $315.76 $1,543 - $1,894
-6 Reduced 0.47%
1,268 $372,000
Q4 2021

Feb 08, 2022

SELL
$292.08 - $329.01 $205,624 - $231,623
-704 Reduced 35.59%
1,274 $419,000
Q3 2020

Oct 30, 2020

BUY
$177.16 - $215.33 $11,515 - $13,996
65 Added 3.4%
1,978 $426,000
Q2 2020

Jul 31, 2020

BUY
$128.7 - $176.83 $44,272 - $60,829
344 Added 21.92%
1,913 $338,000
Q1 2020

Apr 30, 2020

BUY
$121.39 - $169.05 $3,277 - $4,564
27 Added 1.75%
1,569 $217,000
Q4 2019

Feb 10, 2020

BUY
$133.47 - $153.48 $205,810 - $236,666
1,542 New
1,542 $237,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $174B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track West Bancorporation Inc Portfolio

Follow West Bancorporation Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Bancorporation Inc, based on Form 13F filings with the SEC.

News

Stay updated on West Bancorporation Inc with notifications on news.